Gain-of-function mutations in KCNK3 cause a developmental disorder with sleep apnea.
Janina SörmannMarcus SchewePeter ProksThibault R H Jouen-TachoireShanlin RaoElena Barbara RielKatherine E AgreAmber BegtrupJohn DeanMaria DescartesJan FischerAlice GardhamCarrie LahnerPaul R MarkSrikanth MuppidiPavel N PichurinJoseph PorrmannJens SchallnerKirstin SmithVolker StraubPradeep VasudevanRebecca WillaertElisabeth P CarpenterKarin E J RödströmMichael G HahnThomas MüllerThomas BaukrowitzMatthew E HurlesCaroline Fiona WrightStephen J TuckerPublished in: Nature genetics (2022)
Sleep apnea is a common disorder that represents a global public health burden. KCNK3 encodes TASK-1, a K<sup>+</sup> channel implicated in the control of breathing, but its link with sleep apnea remains poorly understood. Here we describe a new developmental disorder with associated sleep apnea (developmental delay with sleep apnea, or DDSA) caused by rare de novo gain-of-function mutations in KCNK3. The mutations cluster around the 'X-gate', a gating motif that controls channel opening, and produce overactive channels that no longer respond to inhibition by G-protein-coupled receptor pathways. However, despite their defective X-gating, these mutant channels can still be inhibited by a range of known TASK channel inhibitors. These results not only highlight an important new role for TASK-1 K<sup>+</sup> channels and their link with sleep apnea but also identify possible therapeutic strategies.